Citations

Showing 10 of 108152 citations.

Injectable Catalyst-Free Poly(Propylene Fumarate) System Cross-Linked by Strain Promoted Alkyne–Azide Cycloaddition Click Chemistry for Spine Defect Filling
Liu, Xifeng , Xu, Hao , Waletzki, Brian E., Lu, Lichun , Miller, A. Lee , Lu, Lichun , Miller, Alan Lee

Mayo Clinic

Biomacromolecules | August 9, 2019 | Volume: 20 | Issue: 9 | Pages: 3352-3365

10.1021/acs.biomac.9b00133 | PMID 31398020 Get It

Position-Specific Body Composition Values in Female Collegiate Rugby Union Athletes
Zabriskie, Hannah A. , Stecker, Richard A., Currier, Brad S. , Moon, Jessica M. , Richmond, Scott R., Zabriskie, Hannah A , Currier, Bradley S , Harty, Patrick S. , Jagim, Andrew R. , Kerksick, Chad M.

Mayo Clinic

Journal of Strength & Conditioning Research | August 9, 2019 | Volume: 35 | Issue: 11 | Pages: 3158-3163

10.1519/jsc.0000000000003314 | PMID 31403573 Get It

Abstract Harty, PS, Zabriskie, HA, Stecker, RA, Currier, BS, Moon, JM, Richmond, SR, Jagim, AR, and Kerksick, CM. Position-specific body composition values in female collegiate rugby union athletes. J Strength Cond Res 35(11): 3158–3163, 2021—Rugby union is a full-contact, intermittent team sport. Anthropometric characteristics of rugby union athletes have been shown to influence suitability for a given position and affect performance. However, little anthropometric data exist in female rugby union athletes. Thus, the purpose of this study was to report position-specific anthropometric, body composition, and bone density values in female collegiate rugby union athletes and to identify between-position differences in these variables. This investigation was a cross-sectional study involving 101 female collegiate rugby union athletes, categorized as forwards and backs as well as by position (props, hookers, locks, flankers, number 8 forwards, halfback, fly-half, centers, wings, and fullbacks). Anthropometric characteristics of all athletes were measured, and body composition was assessed via dual-energy x-ray absorptiometry. Outcome variables included age, height, body mass, BMI, body fat percentage, fat mass (FM), FM index, fat-free mass (FFM), FFM index, lean soft tissue, bone mineral content, bone mineral area, and bone mineral density. Anthropometric and body composition differences between forwards and backs were identified via independent t -tests and Mann-Whitney U tests, depending on normality of the variable. Between-position differences were assessed using one-way analysis of variances (ANOVAs) with Tukey post-hoc comparisons or Welch's ANOVA with Dunnett's T3 post-hoc test. Significant differences ( p < 0.014) were identified between forwards and backs for every anthropometric variable, with forwards displaying greater height (167.7 ± 7.2 cm), body mass (81.5 ± 15.1 kg), and body fat percentage (28.2 ± 6.1%) relative to backs (164.5 ± 5.1 cm; 64.5 ± 7.7 kg; 21.9 ± 3.7%). Likewise, significant differences were identified for every anthropometric variable between several positions ( p < 0.01). Significant ( p < 0.05) interposition differences were identified within the subgroup of forwards, but not within the subgroup of backs. The present investigation is the first to report position-specific anthropometric and body composition data in female collegiate rugby union athletes. The results of this study can be used by rugby union coaches for recruiting and personnel decisions, to determine a player's suitability for a given position, and to further inform training and nutritional interventions in this population.
Pitfalls of a Mixed Metabolic Response at PET/CT
Clark, Michael , Packard, Annie T. , Johnson, Derek R. , Johnson, Geoffrey B. , Clark, Michael S , Packard, Ann T., Johnson, Geoff B, Johnson, Derek R , Johnson, Geoffrey B

Mayo Clinic

RadioGraphics | August 9, 2019 | Volume: 39 | Issue: 5 | Pages: 1461-1475

10.1148/rg.2019180093 | PMID 31398089 Get It

Optimizing Image Quality When Evaluating Blood Flow at Doppler US: A Tutorial
Imanzadeh, Amir, Menias, Christine O. , Pourjabbar, Sarvenaz , Mustafa, A. , Nezami, Nariman , Spektor, Michael , Pellerito, John S. , Revzin, Margarita V. , Menias, Christine, Pourjabbar, Sarvenaz , Mustafa, Adel, Nezami, Nariman , Pellerito, John S

Mayo Clinic

RadioGraphics | August 9, 2019 | Volume: 39 | Issue: 5 | Pages: 1501-1523

10.1148/rg.2019180055 | PMID 31398088 Get It

Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy
Neumann, Hartmut P.H., Tsoy, Uliana, Amodru, Vincent , Walz, Martin K. , Kaur, Ravinder Jeet , McKenzie, Travis J. , Qi, Xiao-Ping , Bandgar, Tushar , Petrov, Roman , Yukina, M. Yu. , Roslyakova, Anna , Horst‐Schrivers, Anouk N.A. van der , Berends, Annika M.A. , Hoff, Ana O. , Castroneves, Luciana Audi , Rizzati, Silvia, Mian, Caterina , Dvořáková, Šárka , Hasse-Lazar, Kornelia , Kvachenyuk, Andrey, Pęczkowska, Mariola , Loli, Paola , Erenler, Feyza , Krauß, Tobias , Almeida, Madson Q. , Liu, Longfei , Zhu, Feizhou , Recasens, Mònica, Wohllk, Nelson , Corssmit, Eleonora P.M. , Kunavisarut, Tada , Schalin‐Jäntti, Camilla , Castinetti, Frédéric , Vlček, Petr , Beltsevich, D. G. , Егоров, В. И. , Schiavi, Francesca , Links, Thera P. , Lechan, Ronald M. , Bausch, Birke, Group, for the International Bilateral-Pheochromocytoma-Registry, Ngeow, Joanne , Jarząb, Barbara , Hudiakova, N. V. , Fragoso, Maria Candida Barisson Villares , Grineva, Elena , Tsoy, U. A. , Opocher, Giuseppe , Ngeow, Joanne , Bancos, Irina , Tirosh, Amit , Ferrara, Alfonso Massimiliano , Recasens, Monica, Shafigullina, Zulfiya R. , Calissendorff, Jan , Grozinsky‐Glasberg, Simona , Egorov, Viacheslav I., Young, William F. , Eng, Charis , Almeida, Madson Q

Mayo Clinic

JAMA Network Open | August 9, 2019 | Volume: 2 | Issue: 8 | Pages: e198898

10.1001/jamanetworkopen.2019.8898 | PMID 31397861 Get It

Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes
Moschini, Marco , Zamboni, Stefania , Mathiéu, Romain , Xylinas, Évanguelos , Tan, Wei Shen , Kelly, John D. , Simone, Giuseppe , Meraney, Anoop, Krishna, Suprita, Konety, Badrinath R. , Mattei, Agostino , Baumeister, Philipp , Mordasini, Livio , Montorsi, Francesco , Briganti, Alberto , Sanchez‐Salas, Rafael , Cathelineau, Xavier , Rink, Michael , Karakiewicz, Pierre I. , Koupparis, Anthony , Kassouf, Wassim , Scherr, Douglas S. , Ploussard, Guillaume , Boorjian, Stephen A. , Sooriakumaran, Prasanna , Larcher, Alessandro , Simone, Giuseppe , Gallina, Andrea , Lotan, Yair , Moschini, Marco , Soria, Francesco , Baumeister, Philipp, Gallina, Andrea , Stabile, Armando , Necchi, Andrea , Rouprêt, Morgan , Lotan, Yair , Shariat, Shahrokh F.

Mayo Clinic

Journal of Clinical Medicine | August 9, 2019 | Volume: 8 | Issue: 8 | Pages: 1192

10.3390/jcm8081192 | PMID 31395826 Get It

Background: To assess the differential effect of robotic assisted radical cystectomy (RARC) versus open radical cystectomy (ORC) on survival outcomes in matched analyses performed on a large multicentric cohort. Methods: The study included 9757 patients with urothelial bladder cancer (BCa) treated in a consecutive manner at each of 25 institutions. All patients underwent radical cystectomy with bilateral pelvic lymphadenectomy. To adjust for potential selection bias, propensity score matching 2:1 was performed with two ORC patients matched to one RARC patient. The propensity-matched cohort included 1374 patients. Multivariable competing risk analyses accounting for death of other causes, tested association of surgical technique with recurrence and cancer specific mortality (CSM), before and after propensity score matching. Results: Overall, 767 (7.8%) patients underwent RARC and 8990 (92.2%) ORC. The median follow-up before and after propensity matching was 81 and 102 months, respectively. In the overall population, the 3-year recurrence rates and CSM were 37% vs. 26% and 34% vs. 24% for ORC vs. RARC (all p values > 0.1), respectively. On multivariable Cox regression analyses, RARC and ORC had similar recurrence and CSM rates before and after matching (all p values > 0.1). Conclusions: Patients treated with RARC and ORC have similar survival outcomes. This data is helpful in consulting patients until long term survival outcomes of level one evidence is available.
Epigenome Mapping Identifies Tumor-Specific Gene Expression in Primary Rectal Cancer
Flebbe, Hannah, Hamdan, Feda H. , Kari, Vijayalakshmi, Kitz, Julia , Gaedcke, Jochen , Ghadimi, Β. Michael, Johnsen, Steven A. , Grade, Marian , Johnsen, Steven A

Mayo Clinic

Cancers | August 9, 2019 | Volume: 11 | Issue: 8 | Pages: 1142

10.3390/cancers11081142 | PMID 31404997 Get It

Epigenetic alterations play a central role in cancer development and progression. The acetylation of histone 3 at lysine 27 (H3K27ac) specifically marks active genes. While chromatin immunoprecipitation (ChIP) followed by next-generation sequencing (ChIP-seq) analyses are commonly performed in cell lines, only limited data are available from primary tumors. We therefore examined whether cancer-specific alterations in H3K27ac occupancy can be identified in primary rectal cancer. Tissue samples from primary rectal cancer and matched mucosa were obtained. ChIP-seq for H3K27ac was performed and differentially occupied regions were identified. The expression of selected genes displaying differential occupancy between tumor and mucosa were examined in gene expression data from an independent patient cohort. Differential expression of four proteins was further examined by immunohistochemistry. ChIP-seq for H3K27ac in primary rectal cancer and matched mucosa was successfully performed and revealed differential binding on 44 regions. This led to the identification of genes with increased H3K27ac, i.e., RIPK2, FOXQ1, KRT23, and EPHX4, which were also highly upregulated in primary rectal cancer in an independent dataset. The increased expression of these four proteins was confirmed by immunohistochemistry. This study demonstrates the feasibility of ChIP-seq-based epigenome mapping of primary rectal cancer and confirms the value of H3K27ac occupancy to predict gene expression differences.
Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma
Buszek, Samantha M. , Ludmir, Ethan B. , Grosshans, David R. , McAleer, Mary Frances , McGovern, Susan L. , Harrison, Douglas J. , Okcu, M. Fatih , Chintagumpala, Murali , Mahajan, Anita , Paulino, Arnold C. , Paulino, Arnold C , Ludmir, Ethan B

Mayo Clinic

Pediatric Blood & Cancer | August 9, 2019 | Volume: 66 | Issue: 11 | Pages: No page available

10.1002/pbc.27952 | PMID 31397065 Get It

AbstractPurpose/Objective(s)Bladder and prostate are unfavorable sites for rhabdomyosarcoma (B/P‐RMS), and represent a challenging location for radiotherapy.Materials/MethodsNineteen patients with B/P‐RMS were enrolled on a prospective registry protocol (2008‐2017) and treated with chemotherapy, proton beam therapy (PBT), and surgical resection (n = 8; 42%). Emphasis was given to treatment technique, disease‐related outcomes, and toxicity associated with PBT.ResultsThe majority of patients had bladder RMS (74%) of embryonal histology (95%), Group III (68%), and intermediate‐risk disease by Children's Oncology Group (COG) risk stratification (89%). Seven patients (37%) had primary tumors >5 cm in size. All patients were treated according to COG protocols. With a median follow‐up of 66.2 months, 5‐year overall survival (OS) and progression‐free survival (PFS) were 76%. Four patients (21%) experienced disease relapse, all presenting with local failure. The 5‐year local control (LC) rate was 76%. Tumor size predicted LC, with 5‐year LC for patients with >5 cm tumors being 43% versus 100% for those with ≤5 cm tumors (P = .006). Univariate analysis demonstrated an effect of tumor size on OS (tumor >5 cm, hazard ratio [HR] 17.7, P = .049) and PFS (HR 17.7, P = .049). Acute grade 2 toxicity was observed in two patients (11%, transient proctitis). Late grade 2+ toxicity was observed in three patients (16%; n = 1 grade 2 skeletal deformity; n = 3 transient grade 2 urinary incontinence; one patient experienced both).ConclusionsPBT for B/P‐RMS affords promising disease‐related outcomes with an acceptable toxicity profile. Higher local failure rates were observed for larger tumors, supporting dose‐escalation components of ongoing RMS clinical trials.
Risk factors of neurovascular ageing in women
Miller, Virginia M. , Jayachandran, Muthuvel , Barnes, Jill N. , Kantarci, Kejal , Rocca, Walter A. , Barnes, J N , Kantarci, Kejal , Mielke, Michelle M.

Mayo Clinic

Journal of Neuroendocrinology | August 9, 2019 | Volume: 32 | Issue: 1 | Pages: No page available

10.1111/jne.12777 | PMID 31397036 Get It

AbstractBiological sex and changes in sex hormones throughout life influence all aspects of health and disease. In women, changes in sex hormonal status reflect ovarian function, pregnancy and the use of exogenous hormonal treatments. Longitudinal data from defined cohorts of women will help to identify mechanisms by which the hormonal milieu contributes to cerebrovascular ageing, brain structure and ultimately cognition. This review summarises the phenotypes of three cohorts of women identified through the medical records‐linkage system of the Rochester Epidemiology Project and the Mayo Clinic Specialized Center of Research Excellence (SCORE) on Sex Differences: (i) menopausal women with histories of normotensive or hypertensive pregnancies; (ii) women who had bilateral oophorectomy ≤45 years of age; and (iii) women who experienced natural menopause and used menopausal hormone treatments for 4 years. Data from these cohorts will influence the design of follow‐up studies concerning how sex hormonal status affects neurovascular ageing in women.
The impact of pulsed electromagnetic field therapy on blood pressure and circulating nitric oxide levels: a double blind, randomized study in subjects with metabolic syndrome
Kim, Chul‐Ho , Wheatley, Courtney M. , Stewart, Glenn M. , Yeo, Dongwook , Shen, Win-Kuang, Johnson, Bruce D. , Wheatley-Guy, Courtney M

Mayo Clinic

Blood Pressure | August 9, 2019 | Volume: 29 | Issue: 1 | Pages: 47-54

10.1080/08037051.2019.1649591 | PMID 31394939 Get It